Rank | Gene Set | Z-score |
---|---|---|
1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.30961278 |
2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.87708307 |
3 | negative regulation of cell killing (GO:0031342) | 6.87708307 |
4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.71043215 |
5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.71043215 |
6 | modulation by symbiont of host immune response (GO:0052553) | 6.71043215 |
7 | positive regulation by symbiont of host defense response (GO:0052509) | 6.71043215 |
8 | modulation by symbiont of host defense response (GO:0052031) | 6.71043215 |
9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.71043215 |
10 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.13790138 |
11 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.83155678 |
12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.71105241 |
13 | detection of molecule of bacterial origin (GO:0032490) | 5.59266287 |
14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.48494307 |
15 | macrophage activation involved in immune response (GO:0002281) | 5.48379057 |
16 | detection of other organism (GO:0098543) | 5.44448420 |
17 | neutrophil activation involved in immune response (GO:0002283) | 5.28810620 |
18 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.14385636 |
19 | detection of external biotic stimulus (GO:0098581) | 5.10148164 |
20 | detection of bacterium (GO:0016045) | 5.03719332 |
21 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.96411641 |
22 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.85294589 |
23 | response to interleukin-15 (GO:0070672) | 4.84700726 |
24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.83411826 |
25 | response to peptidoglycan (GO:0032494) | 4.70982738 |
26 | cellular extravasation (GO:0045123) | 4.67864646 |
27 | microglial cell activation (GO:0001774) | 4.66196104 |
28 | response to host immune response (GO:0052572) | 4.65946114 |
29 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.65946114 |
30 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.62115283 |
31 | leukocyte aggregation (GO:0070486) | 4.60093430 |
32 | cellular response to interleukin-15 (GO:0071350) | 4.57191159 |
33 | neutrophil activation (GO:0042119) | 4.52048660 |
34 | detection of biotic stimulus (GO:0009595) | 4.42325034 |
35 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.37237824 |
36 | negative regulation of interleukin-12 production (GO:0032695) | 4.36723406 |
37 | respiratory burst (GO:0045730) | 4.35629674 |
38 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.28177055 |
39 | response to host (GO:0075136) | 4.28177055 |
40 | response to host defenses (GO:0052200) | 4.28177055 |
41 | neutrophil mediated immunity (GO:0002446) | 4.23873924 |
42 | macrophage activation (GO:0042116) | 4.15960541 |
43 | regulation of gamma-delta T cell activation (GO:0046643) | 4.11754080 |
44 | granulocyte activation (GO:0036230) | 4.02301280 |
45 | cellular response to type I interferon (GO:0071357) | 4.00786243 |
46 | type I interferon signaling pathway (GO:0060337) | 4.00786243 |
47 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 4.00440633 |
48 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.99816874 |
49 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.98384253 |
50 | response to type I interferon (GO:0034340) | 3.97215995 |
51 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.95112387 |
52 | myeloid cell activation involved in immune response (GO:0002275) | 3.83117191 |
53 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.81020155 |
54 | immunoglobulin mediated immune response (GO:0016064) | 3.77102213 |
55 | negative regulation of T cell mediated immunity (GO:0002710) | 3.71201178 |
56 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.68307793 |
57 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.65484026 |
58 | myeloid leukocyte mediated immunity (GO:0002444) | 3.63294359 |
59 | regulation of mast cell degranulation (GO:0043304) | 3.59639193 |
60 | response to interferon-alpha (GO:0035455) | 3.59050580 |
61 | dendritic cell migration (GO:0036336) | 3.48432671 |
62 | B cell receptor signaling pathway (GO:0050853) | 3.47140016 |
63 | dendritic cell chemotaxis (GO:0002407) | 3.43664608 |
64 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.38123706 |
65 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.37934268 |
66 | positive regulation of mast cell activation (GO:0033005) | 3.35355000 |
67 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.34962371 |
68 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.32207137 |
69 | positive regulation of interferon-alpha production (GO:0032727) | 3.32067291 |
70 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.30289057 |
71 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.26272032 |
72 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.26272032 |
73 | leukocyte degranulation (GO:0043299) | 3.23695195 |
74 | negative regulation of phagocytosis (GO:0050765) | 3.20755493 |
75 | regulation of T cell tolerance induction (GO:0002664) | 3.19224662 |
76 | regulation of mast cell activation (GO:0033003) | 3.19053702 |
77 | regulation of B cell differentiation (GO:0045577) | 3.17094671 |
78 | regulation of leukocyte degranulation (GO:0043300) | 3.16608608 |
79 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.15211028 |
80 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.15072514 |
81 | regulation of tolerance induction (GO:0002643) | 3.15048366 |
82 | defense response to protozoan (GO:0042832) | 3.14222673 |
83 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.12850943 |
84 | negative regulation of type 2 immune response (GO:0002829) | 3.11990989 |
85 | germinal center formation (GO:0002467) | 3.08865949 |
86 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.05785137 |
87 | regulation of interferon-alpha production (GO:0032647) | 3.05770289 |
88 | B cell mediated immunity (GO:0019724) | 3.03243407 |
89 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.99424062 |
90 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.98888855 |
91 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.97816831 |
92 | negative regulation of innate immune response (GO:0045824) | 2.95178199 |
93 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.94536932 |
94 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.94407998 |
95 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.94407998 |
96 | myeloid leukocyte activation (GO:0002274) | 2.92985715 |
97 | neutrophil chemotaxis (GO:0030593) | 2.92722376 |
98 | regulation of regulatory T cell differentiation (GO:0045589) | 2.91244199 |
99 | response to muramyl dipeptide (GO:0032495) | 2.90285973 |
100 | regulation of regulated secretory pathway (GO:1903305) | 2.88468145 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.88937721 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.03096793 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.56535546 |
4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.92315199 |
5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.86579701 |
6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.84616129 |
7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.30328088 |
8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.26698357 |
9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.24888783 |
10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.06820299 |
11 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.90389535 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.87879832 |
13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83369198 |
14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.80466505 |
15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.74438437 |
16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.71657602 |
17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.53895027 |
18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.46798263 |
19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.46275343 |
20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.42661566 |
21 | MAF_26560356_Chip-Seq_TH1_Human | 2.36090256 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 2.35497251 |
23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.30797230 |
24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.22949429 |
25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.21644530 |
26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.14278405 |
27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.13808119 |
28 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.12355582 |
29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.07027049 |
30 | UTX_26944678_Chip-Seq_JUKART_Human | 2.06873831 |
31 | MYB_26560356_Chip-Seq_TH1_Human | 2.03248769 |
32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.96816227 |
33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.93986016 |
34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.92310499 |
35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.86495560 |
36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85001878 |
37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79451251 |
38 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.78636051 |
39 | MYC_22102868_ChIP-Seq_BL_Human | 1.78486670 |
40 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.78457173 |
41 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.77988717 |
42 | MAF_26560356_Chip-Seq_TH2_Human | 1.70031337 |
43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.64304411 |
44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62232470 |
45 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.60504014 |
46 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60253388 |
47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.58768989 |
48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.58374811 |
49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52644657 |
50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.44552217 |
51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.43341589 |
52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43094324 |
53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42503047 |
54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39741649 |
55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38855997 |
56 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.38593961 |
57 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36066330 |
58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.36032229 |
59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35415627 |
60 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.34150738 |
61 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.33719060 |
62 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.33108143 |
63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26486298 |
64 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26269171 |
65 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23592049 |
66 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.22492153 |
67 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21373281 |
68 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20355842 |
69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19906875 |
70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19548878 |
71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17311604 |
72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16646981 |
73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16620757 |
74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16176874 |
75 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15211715 |
76 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.14665761 |
77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.14435976 |
78 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13096195 |
79 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.12698595 |
80 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12215279 |
81 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.08671611 |
82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08199931 |
83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.08043933 |
84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06371474 |
85 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03591073 |
86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03018445 |
87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02813562 |
88 | GATA1_19941826_ChIP-Seq_K562_Human | 0.96300080 |
89 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.90711923 |
90 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90201762 |
91 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87477500 |
92 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87163190 |
93 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86764269 |
94 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80110454 |
95 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78816570 |
96 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.77637108 |
97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.77196454 |
98 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.76357565 |
99 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.73654431 |
100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.72864633 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003724_increased_susceptibility_to | 6.21833165 |
2 | MP0003436_decreased_susceptibility_to | 4.37467074 |
3 | MP0001835_abnormal_antigen_presentation | 3.78519238 |
4 | MP0003303_peritoneal_inflammation | 3.67898826 |
5 | MP0002419_abnormal_innate_immunity | 3.22560388 |
6 | MP0009785_altered_susceptibility_to | 3.02880487 |
7 | MP0005025_abnormal_response_to | 2.95269629 |
8 | MP0005671_abnormal_response_to | 2.93247045 |
9 | MP0001800_abnormal_humoral_immune | 2.90611064 |
10 | MP0000685_abnormal_immune_system | 2.77643243 |
11 | MP0005000_abnormal_immune_tolerance | 2.76941102 |
12 | MP0003191_abnormal_cellular_cholesterol | 2.71321246 |
13 | MP0005387_immune_system_phenotype | 2.66561116 |
14 | MP0001790_abnormal_immune_system | 2.66561116 |
15 | MP0002723_abnormal_immune_serum | 2.60147895 |
16 | MP0002420_abnormal_adaptive_immunity | 2.53295957 |
17 | MP0001819_abnormal_immune_cell | 2.50736073 |
18 | MP0006082_CNS_inflammation | 2.48469470 |
19 | MP0002452_abnormal_antigen_presenting | 2.45178236 |
20 | MP0008260_abnormal_autophagy | 2.35412138 |
21 | MP0001533_abnormal_skeleton_physiology | 2.28533694 |
22 | MP0003300_gastrointestinal_ulcer | 2.25014197 |
23 | MP0002132_abnormal_respiratory_system | 2.23539169 |
24 | MP0002277_abnormal_respiratory_mucosa | 2.14658017 |
25 | MP0002148_abnormal_hypersensitivity_rea | 2.11029070 |
26 | MP0002405_respiratory_system_inflammati | 2.01550351 |
27 | MP0003763_abnormal_thymus_physiology | 1.98535669 |
28 | MP0002398_abnormal_bone_marrow | 1.89655332 |
29 | MP0000716_abnormal_immune_system | 1.87934515 |
30 | MP0003828_pulmonary_edema | 1.87603104 |
31 | MP0005464_abnormal_platelet_physiology | 1.83279999 |
32 | MP0002396_abnormal_hematopoietic_system | 1.80237687 |
33 | MP0005451_abnormal_body_composition | 1.77526505 |
34 | MP0003866_abnormal_defecation | 1.72908535 |
35 | MP0001845_abnormal_inflammatory_respons | 1.72669099 |
36 | MP0010155_abnormal_intestine_physiology | 1.70286138 |
37 | MP0000465_gastrointestinal_hemorrhage | 1.70176495 |
38 | MP0004381_abnormal_hair_follicle | 1.69657268 |
39 | MP0004883_abnormal_blood_vessel | 1.66565377 |
40 | MP0009278_abnormal_bone_marrow | 1.65426359 |
41 | MP0003183_abnormal_peptide_metabolism | 1.62571532 |
42 | MP0002722_abnormal_immune_system | 1.57175050 |
43 | MP0009764_decreased_sensitivity_to | 1.55538801 |
44 | MP0003172_abnormal_lysosome_physiology | 1.54462223 |
45 | MP0000689_abnormal_spleen_morphology | 1.54135663 |
46 | MP0004947_skin_inflammation | 1.50234671 |
47 | MP0002429_abnormal_blood_cell | 1.46182715 |
48 | MP0000703_abnormal_thymus_morphology | 1.44984116 |
49 | MP0008469_abnormal_protein_level | 1.44513073 |
50 | MP0000858_altered_metastatic_potential | 1.44238729 |
51 | MP0009333_abnormal_splenocyte_physiolog | 1.36808661 |
52 | MP0005164_abnormal_response_to | 1.32328822 |
53 | MP0003075_altered_response_to | 1.25385499 |
54 | MP0005310_abnormal_salivary_gland | 1.23500619 |
55 | MP0001545_abnormal_hematopoietic_system | 1.19457570 |
56 | MP0005397_hematopoietic_system_phenotyp | 1.19457570 |
57 | MP0001851_eye_inflammation | 1.19336624 |
58 | MP0003690_abnormal_glial_cell | 1.17658307 |
59 | MP0002998_abnormal_bone_remodeling | 1.06201798 |
60 | MP0002166_altered_tumor_susceptibility | 1.05695737 |
61 | MP0005166_decreased_susceptibility_to | 0.96839207 |
62 | MP0004510_myositis | 0.95260565 |
63 | MP0003448_altered_tumor_morphology | 0.91211958 |
64 | MP0000569_abnormal_digit_pigmentation | 0.91060514 |
65 | MP0005390_skeleton_phenotype | 0.90278951 |
66 | MP0003045_fibrosis | 0.88708392 |
67 | MP0005075_abnormal_melanosome_morpholog | 0.85503536 |
68 | MP0009763_increased_sensitivity_to | 0.83650680 |
69 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82462165 |
70 | MP0000343_altered_response_to | 0.80419462 |
71 | MP0001663_abnormal_digestive_system | 0.75627673 |
72 | MP0004130_abnormal_muscle_cell | 0.75395275 |
73 | MP0000015_abnormal_ear_pigmentation | 0.75196198 |
74 | MP0008004_abnormal_stomach_pH | 0.74795416 |
75 | MP0004808_abnormal_hematopoietic_stem | 0.69748841 |
76 | MP0008874_decreased_physiological_sensi | 0.69187594 |
77 | MP0002928_abnormal_bile_duct | 0.67758811 |
78 | MP0000604_amyloidosis | 0.66832853 |
79 | MP0000490_abnormal_crypts_of | 0.65311392 |
80 | MP0001986_abnormal_taste_sensitivity | 0.64936827 |
81 | MP0004484_altered_response_of | 0.64460816 |
82 | MP0003656_abnormal_erythrocyte_physiolo | 0.63790466 |
83 | MP0009765_abnormal_xenobiotic_induced | 0.62951445 |
84 | MP0004858_abnormal_nervous_system | 0.62391013 |
85 | MP0003252_abnormal_bile_duct | 0.61330243 |
86 | MP0002006_tumorigenesis | 0.61079799 |
87 | MP0005388_respiratory_system_phenotype | 0.59927878 |
88 | MP0002133_abnormal_respiratory_system | 0.59927878 |
89 | MP0003795_abnormal_bone_structure | 0.59893348 |
90 | MP0005377_hearing/vestibular/ear_phenot | 0.58726661 |
91 | MP0003878_abnormal_ear_physiology | 0.58726661 |
92 | MP0003806_abnormal_nucleotide_metabolis | 0.58224883 |
93 | MP0000249_abnormal_blood_vessel | 0.57892687 |
94 | MP0002332_abnormal_exercise_endurance | 0.57320045 |
95 | MP0003787_abnormal_imprinting | 0.57214712 |
96 | MP0005248_abnormal_Harderian_gland | 0.56661267 |
97 | MP0001853_heart_inflammation | 0.56021242 |
98 | MP0001958_emphysema | 0.53102157 |
99 | MP0005319_abnormal_enzyme/_coenzyme | 0.53023104 |
100 | MP0005376_homeostasis/metabolism_phenot | 0.51501419 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 7.26025002 |
2 | Myositis (HP:0100614) | 6.49992213 |
3 | Recurrent abscess formation (HP:0002722) | 6.38578538 |
4 | Orchitis (HP:0100796) | 6.38316347 |
5 | Recurrent bacterial skin infections (HP:0005406) | 6.26522557 |
6 | Optic neuritis (HP:0100653) | 6.01149287 |
7 | Retrobulbar optic neuritis (HP:0100654) | 6.01149287 |
8 | Abnormality of macrophages (HP:0004311) | 5.41167786 |
9 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.37283045 |
10 | Stomatitis (HP:0010280) | 5.01411159 |
11 | Gastrointestinal infarctions (HP:0005244) | 4.89963970 |
12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.85056536 |
13 | Keratoconjunctivitis sicca (HP:0001097) | 4.44947480 |
14 | Recurrent fungal infections (HP:0002841) | 4.37120891 |
15 | Obstructive lung disease (HP:0006536) | 4.30874502 |
16 | Chronic obstructive pulmonary disease (HP:0006510) | 4.30874502 |
17 | Mediastinal lymphadenopathy (HP:0100721) | 4.23008443 |
18 | Meningitis (HP:0001287) | 4.14570865 |
19 | Keratoconjunctivitis (HP:0001096) | 4.12174398 |
20 | Recurrent skin infections (HP:0001581) | 4.12059059 |
21 | Encephalitis (HP:0002383) | 4.05996650 |
22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.04298910 |
23 | Gingivitis (HP:0000230) | 3.96595441 |
24 | Hypochromic microcytic anemia (HP:0004840) | 3.92449365 |
25 | Spontaneous hematomas (HP:0007420) | 3.90379466 |
26 | Peritonitis (HP:0002586) | 3.72999929 |
27 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.70405193 |
28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.70405193 |
29 | Urticaria (HP:0001025) | 3.68232478 |
30 | Vasculitis (HP:0002633) | 3.57679107 |
31 | Increased IgE level (HP:0003212) | 3.56714727 |
32 | Chest pain (HP:0100749) | 3.48910963 |
33 | Hypochromic anemia (HP:0001931) | 3.39222827 |
34 | Cellulitis (HP:0100658) | 3.31385007 |
35 | T lymphocytopenia (HP:0005403) | 3.30569892 |
36 | Episodic fever (HP:0001954) | 3.27705407 |
37 | Hemoptysis (HP:0002105) | 3.24150681 |
38 | Abnormality of T cell number (HP:0011839) | 3.21047815 |
39 | Arterial thrombosis (HP:0004420) | 3.18512555 |
40 | Gingival bleeding (HP:0000225) | 3.14544425 |
41 | Prolonged bleeding time (HP:0003010) | 3.08769154 |
42 | Anorexia (HP:0002039) | 3.04064442 |
43 | Pulmonary infiltrates (HP:0002113) | 3.03040016 |
44 | Leukocytosis (HP:0001974) | 2.93997614 |
45 | Pulmonary embolism (HP:0002204) | 2.93811145 |
46 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.82599620 |
47 | Abnormality of T cells (HP:0002843) | 2.70350279 |
48 | Amyloidosis (HP:0011034) | 2.66246603 |
49 | Increased IgM level (HP:0003496) | 2.63615063 |
50 | Abnormality of the peritoneum (HP:0002585) | 2.62346505 |
51 | Epistaxis (HP:0000421) | 2.61490440 |
52 | Osteomyelitis (HP:0002754) | 2.58755754 |
53 | Inflammation of the large intestine (HP:0002037) | 2.58447985 |
54 | Microcytic anemia (HP:0001935) | 2.53665629 |
55 | Abnormality of the pleura (HP:0002103) | 2.53605273 |
56 | Gangrene (HP:0100758) | 2.51967380 |
57 | Granulocytopenia (HP:0001913) | 2.51665301 |
58 | Recurrent viral infections (HP:0004429) | 2.49141956 |
59 | Gastrointestinal inflammation (HP:0004386) | 2.48341807 |
60 | Sepsis (HP:0100806) | 2.48182382 |
61 | Abnormality of the endocardium (HP:0004306) | 2.40458264 |
62 | Pustule (HP:0200039) | 2.34514421 |
63 | Subacute progressive viral hepatitis (HP:0006572) | 2.30821870 |
64 | Panhypogammaglobulinemia (HP:0003139) | 2.29141711 |
65 | Acute hepatic failure (HP:0006554) | 2.26566467 |
66 | Keratitis (HP:0000491) | 2.25206707 |
67 | Glomerulopathy (HP:0100820) | 2.24493883 |
68 | Abnormality of T cell physiology (HP:0011840) | 2.21078659 |
69 | Lymphopenia (HP:0001888) | 2.18136354 |
70 | Eosinophilia (HP:0001880) | 2.18015171 |
71 | Hypergammaglobulinemia (HP:0010702) | 2.17959381 |
72 | Petechiae (HP:0000967) | 2.17107316 |
73 | Chronic otitis media (HP:0000389) | 2.16117101 |
74 | Acne (HP:0001061) | 2.14180097 |
75 | Skin ulcer (HP:0200042) | 2.13534057 |
76 | Vertigo (HP:0002321) | 2.11451973 |
77 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.08299602 |
78 | Abnormality of the pericardium (HP:0001697) | 2.06497162 |
79 | Slow saccadic eye movements (HP:0000514) | 2.05876112 |
80 | Viral hepatitis (HP:0006562) | 2.05747066 |
81 | Cheilitis (HP:0100825) | 2.00679196 |
82 | Metaphyseal cupping (HP:0003021) | 1.98675228 |
83 | Premature loss of primary teeth (HP:0006323) | 1.94263392 |
84 | Abnormal platelet volume (HP:0011876) | 1.93847056 |
85 | Difficulty running (HP:0009046) | 1.93747201 |
86 | Recurrent bronchitis (HP:0002837) | 1.90386859 |
87 | Recurrent pneumonia (HP:0006532) | 1.89924843 |
88 | Hepatosplenomegaly (HP:0001433) | 1.86902652 |
89 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.85928324 |
90 | Thrombophlebitis (HP:0004418) | 1.83334766 |
91 | Hypermelanotic macule (HP:0001034) | 1.82917751 |
92 | IgM deficiency (HP:0002850) | 1.82278907 |
93 | Skin rash (HP:0000988) | 1.82005747 |
94 | Abnormality of eosinophils (HP:0001879) | 1.81914329 |
95 | Polyneuropathy (HP:0001271) | 1.80635476 |
96 | Nasal polyposis (HP:0100582) | 1.80379302 |
97 | Toxemia of pregnancy (HP:0100603) | 1.80020375 |
98 | Colitis (HP:0002583) | 1.79424787 |
99 | Polycythemia (HP:0001901) | 1.78624263 |
100 | Papilledema (HP:0001085) | 1.74386293 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RIPK4 | 5.00665319 |
2 | IRAK4 | 3.60294885 |
3 | BLK | 3.33997481 |
4 | MAP2K3 | 3.21121432 |
5 | MAP4K1 | 3.19057928 |
6 | TYK2 | 2.94612663 |
7 | CSK | 2.93530422 |
8 | ERN1 | 2.86864409 |
9 | EPHB1 | 2.69584974 |
10 | FES | 2.54093872 |
11 | GRK6 | 2.31434515 |
12 | TNK2 | 2.30382777 |
13 | ZAP70 | 2.01909391 |
14 | TAOK1 | 1.86091319 |
15 | JAK3 | 1.83237168 |
16 | FGR | 1.81640056 |
17 | MAP3K3 | 1.81236388 |
18 | HCK | 1.81120905 |
19 | BTK | 1.77249410 |
20 | TXK | 1.70707002 |
21 | PRPF4B | 1.67839576 |
22 | KSR2 | 1.65004244 |
23 | JAK2 | 1.62093838 |
24 | YES1 | 1.57930227 |
25 | SYK | 1.54466363 |
26 | MAP3K11 | 1.52906806 |
27 | IKBKE | 1.43078470 |
28 | JAK1 | 1.40779236 |
29 | LYN | 1.39650979 |
30 | MAP3K1 | 1.35325855 |
31 | IRAK1 | 1.23385163 |
32 | MAP3K14 | 1.23234605 |
33 | SIK3 | 1.22456825 |
34 | TAOK3 | 1.17121736 |
35 | LCK | 1.10859068 |
36 | MAP3K2 | 1.10618604 |
37 | MAP3K6 | 1.10478770 |
38 | PTK6 | 1.09893487 |
39 | TBK1 | 1.07642539 |
40 | IRAK2 | 1.04897948 |
41 | MARK2 | 1.04183298 |
42 | MATK | 1.00815634 |
43 | CDK19 | 0.99060271 |
44 | MAP3K13 | 0.98959503 |
45 | CSF1R | 0.98292270 |
46 | ITK | 0.96160906 |
47 | KIT | 0.95023337 |
48 | MARK3 | 0.94574213 |
49 | PRKD2 | 0.94173255 |
50 | LRRK2 | 0.93166553 |
51 | MAP2K4 | 0.90881610 |
52 | STK10 | 0.88147278 |
53 | PDK1 | 0.84595838 |
54 | PTK2B | 0.82063724 |
55 | FGFR3 | 0.80303958 |
56 | EPHA3 | 0.78629125 |
57 | TRIB3 | 0.76385409 |
58 | TEC | 0.74750088 |
59 | DYRK1B | 0.74029374 |
60 | SIK2 | 0.73405220 |
61 | PDPK1 | 0.73172017 |
62 | BMPR2 | 0.72740642 |
63 | FGFR4 | 0.72618402 |
64 | FYN | 0.72275313 |
65 | RAF1 | 0.72196538 |
66 | STK11 | 0.71648078 |
67 | SMG1 | 0.71485332 |
68 | TGFBR2 | 0.69062866 |
69 | KSR1 | 0.68963673 |
70 | PIK3CG | 0.68515966 |
71 | MAP3K7 | 0.66553873 |
72 | MAP3K5 | 0.66093379 |
73 | TESK2 | 0.63946768 |
74 | TAOK2 | 0.62010236 |
75 | STK38 | 0.60597000 |
76 | SGK3 | 0.58534231 |
77 | RET | 0.56686975 |
78 | NLK | 0.55969943 |
79 | MAP2K6 | 0.53873952 |
80 | PRKCQ | 0.50034773 |
81 | MAPK12 | 0.48870489 |
82 | DYRK3 | 0.48735679 |
83 | IKBKB | 0.48539932 |
84 | DAPK2 | 0.47742961 |
85 | HIPK2 | 0.47063702 |
86 | WNK1 | 0.44083994 |
87 | SGK2 | 0.43569398 |
88 | PRKCZ | 0.41104677 |
89 | MAPKAPK2 | 0.39216125 |
90 | PRKG2 | 0.38340223 |
91 | CDC42BPA | 0.37908557 |
92 | MAPK7 | 0.37368273 |
93 | PIM1 | 0.36694427 |
94 | RPS6KL1 | 0.36164518 |
95 | RPS6KC1 | 0.36164518 |
96 | ALK | 0.34683710 |
97 | CAMKK1 | 0.34066039 |
98 | RPS6KA6 | 0.30816557 |
99 | SIK1 | 0.30327809 |
100 | CAMKK2 | 0.29268945 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 3.05359201 |
2 | * Leishmaniasis_Homo sapiens_hsa05140 | 2.96655823 |
3 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.62338127 |
4 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.51042841 |
5 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.33831015 |
6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.29266310 |
7 | * Tuberculosis_Homo sapiens_hsa05152 | 2.18526602 |
8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.16130555 |
9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.12836366 |
10 | Measles_Homo sapiens_hsa05162 | 2.07284814 |
11 | Allograft rejection_Homo sapiens_hsa05330 | 2.07175242 |
12 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.97300437 |
13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.95441215 |
14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.92918214 |
15 | Malaria_Homo sapiens_hsa05144 | 1.90877140 |
16 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.85000892 |
17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.81176833 |
18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.76119338 |
19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.66059944 |
20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.62425069 |
21 | Legionellosis_Homo sapiens_hsa05134 | 1.61049660 |
22 | Influenza A_Homo sapiens_hsa05164 | 1.58334415 |
23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.54861075 |
24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.53681270 |
25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.49388004 |
26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49178192 |
27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.48220487 |
28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.44714705 |
29 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42415228 |
30 | * Phagosome_Homo sapiens_hsa04145 | 1.41900657 |
31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41213364 |
32 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.40553981 |
33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.38969063 |
34 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.38664282 |
35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.37922167 |
36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.37448609 |
37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.34716598 |
38 | Hepatitis C_Homo sapiens_hsa05160 | 1.24721192 |
39 | Hepatitis B_Homo sapiens_hsa05161 | 1.23715618 |
40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21028760 |
41 | Platelet activation_Homo sapiens_hsa04611 | 1.16166548 |
42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.14508510 |
43 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.10533607 |
44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.05853891 |
45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02372762 |
46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.01373172 |
47 | Apoptosis_Homo sapiens_hsa04210 | 0.98939558 |
48 | Salmonella infection_Homo sapiens_hsa05132 | 0.98774067 |
49 | Shigellosis_Homo sapiens_hsa05131 | 0.97092788 |
50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94827909 |
51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.94555503 |
52 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93879849 |
53 | Pertussis_Homo sapiens_hsa05133 | 0.92521944 |
54 | Endocytosis_Homo sapiens_hsa04144 | 0.91086355 |
55 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.90527134 |
56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85955802 |
57 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83728986 |
58 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.80894415 |
59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.79876727 |
60 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78453428 |
61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78220548 |
62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77877925 |
63 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77078071 |
64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76804971 |
65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.76483447 |
66 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.72961910 |
67 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72649133 |
68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72564597 |
69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71950460 |
70 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69323391 |
71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67640408 |
72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66804923 |
73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.65410027 |
74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65163466 |
75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63017542 |
76 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62636980 |
77 | Amoebiasis_Homo sapiens_hsa05146 | 0.61388439 |
78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61296708 |
79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60682228 |
80 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60157589 |
81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59498986 |
82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58207081 |
83 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57948584 |
84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56590395 |
85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56045242 |
86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55181069 |
87 | Insulin resistance_Homo sapiens_hsa04931 | 0.53982076 |
88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51737426 |
89 | Asthma_Homo sapiens_hsa05310 | 0.51425509 |
90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.50217479 |
91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48622816 |
92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48020498 |
93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45951158 |
94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.44109290 |
95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43472494 |
96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.43452989 |
97 | Glioma_Homo sapiens_hsa05214 | 0.42765611 |
98 | Prostate cancer_Homo sapiens_hsa05215 | 0.41947555 |
99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41302077 |
100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39641034 |